Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study
- 29 October 2002
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 81 (3), 132-137
- https://doi.org/10.1002/jso.10124
Abstract
Background and Objectives The aim of this study was to investigate whether systematic lymphadenectomy is necessary in suboptimally cytoreduced patients with stage III ovarian carcinoma. Methods Prognostic significance and the effect on survival of systematic pelvic and para-aortic lymphadenectomy were investigated retrospectively in 61 suboptimally debulked patients with stage III ovarian carcinoma. All patients received platinum-based chemotherapy after surgery; 51 patients had been followed for ≥1 year, or until death. Survival curves were calculated according to the Kaplan-Meier method and were evaluated by log-rank test. Results Most patients had stage IIIC disease (60.7%), poorly differentiated tumor (45.9%), and serous histological type (59%). Systematic pelvic and para-aortic lymphadenectomy was performed in 29 patients (47.5%). Lymph node metastases were found in 17 (58.6%) patients; the median number of metastatic nodes was 7 (5–10). Lymph node metastasis was significantly higher in patients with residual disease of >2 cm (P < 0.05). Both univariate and multivariate analyses showed that systematic pelvic and para-aortic lymphadenectomy was not a significant prognostic factor (P > 0.05). In lymph node-dissected patients, survival was significantly longer in patients with minimal residual tumor than in those with residual tumor size >2 cm (P = 0.005). Conclusions Lymphadenectomy seems not to have an evident prognostic value and a benefit on survival in suboptimally debulked patients with stage III ovarian carcinoma. J. Surg. Oncol. 2002;81:132–137.Keywords
This publication has 20 references indexed in Scilit:
- What Are the Current Surgical Objectives, Strategies, and Technical Capabilities of Gynecologic Oncologists Treating Advanced Epithelial Ovarian Cancer?Gynecologic Oncology, 2001
- Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignanciesPublished by Ovid Technologies (Wolters Kluwer Health) ,2000
- Pelvic and Paraortic Lymph Nodal Status in Advanced Ovarian Cancer and SurvivalGynecologic Oncology, 1999
- Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective StudyGynecologic Oncology, 1998
- Systematic Pelvic and Paraaortic Lymphadenectomy for Advanced Ovarian Cancer: Prognostic Significance of Node MetastasesGynecologic Oncology, 1996
- Prognostic evaluation of lymphadenectomy for epithelial ovarian cancerJournal of Surgical Oncology, 1995
- Lymphadenectomy in stage I ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1994
- Anatomical and Pathological Study of Retroperitoneal Nodes in Epithelial Ovarian CancerGynecologic Oncology, 1993
- Patterns of pelvic and paraaortic lymph node involvement in ovarian cancerGynecologic Oncology, 1991
- AnnouncementGynecologic Oncology, 1986